A Safety, Efficacy and Systemic Exposure Study of CD5789 Cream in Adults and Adolescents With Lamellar Ichthyosis
Condition:   Lamellar Ichthyosis Interventions:   Drug: CD5789 Cream 200 µg/g;   Drug: CD5789 Cream 100 µg/g;   Drug: CD5789 Cream Vehicle Sponsor:   Mayne Pharma International Pty Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 12, 2018 Category: Research Source Type: clinical trials